aTYR PHARMA INC (ATYR)

CIK 1339970 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for aTYR PHARMA INC.

Recent SEC filings

FiledFormAccession number
Nov 6, 202610-Q0001339970-26-000081
Nov 5, 20268-K0001339970-26-000076
Nov 4, 2026SCHEDULE 13G/A0001623632-26-001648
Oct 27, 20268-K0001339970-26-000071
Oct 16, 20268-K0001339970-26-000068
Oct 7, 2026SCHEDULE 13G/A0001623632-26-001548
Oct 1, 202630002156611-26-000008
Oct 1, 202640002156611-26-000010
Sep 24, 20268-K0001339970-26-000065
Sep 11, 2026DEF 14A0001339970-26-000061
Aug 31, 2026PRE 14A0001339970-26-000058
Aug 7, 20268-K0001339970-26-000051
Aug 7, 202610-Q0001339970-26-000053
Aug 7, 2026S-80001339970-26-000055
Aug 6, 2026SCHEDULE 13G/A0000315066-26-001937
Jul 31, 20268-K0001339970-26-000042
Jul 27, 2026SCHEDULE 13G/A0002012383-26-002254
Jul 8, 2026SCHEDULE 13G/A0001623632-26-000980
Jun 8, 20268-K0001339970-26-000039
Jun 5, 2026SCHEDULE 13G/A0000315066-26-001409
Jun 1, 20268-K0001339970-26-000036
May 28, 202640001236447-26-000006
May 15, 20268-K0001339970-26-000030
May 15, 202610-Q0001339970-26-000033
May 13, 202640001781292-26-000003